1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Treatment D: new trials by email Literature Review of Treatment D trials Research Report on Treatment D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma Treatment A, Treatment B, Treatment C - Asthma; Eosinophilic | Phase 3 | Terminated | Chiesi Farmaceutici S.p.A. | 810 | 2019-08-28 | 2022-04-08 |
| Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers Cohort 1: Lubiprostone Capsule, Fasted, Cohort 1: Lubiprostone Sprinkle Formulation, Fasted, Cohort 2: Lubiprostone Sprinkle Formulation, Fed - Healthy Volunteers | Phase 3 | Completed | Sucampo Pharma Americas, LLC | 49 | 2016-11-16 | 2020-03-09 |
Chiesi Farmaceutici S.p.A. (1) · Sucampo Pharma Americas, LLC (1)
Bulgaria (1) · United States (1)
2018 (1)